NCT05775198View on ClinicalTrials.gov

Effect of Intrauterine Administration of Autologous PBMC Modulated With IFNt on IVF Outcome

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 13, 2026

Study Completion Date

April 28, 2026

Conditions
Infertility, FemaleIVF
Interventions
BIOLOGICAL

PBMC immunomodulated with IFNt

Autologous peripheral blood mononuclear cells (PBMC) isolated using a standard protocol will be cultured in the presence of interferon tau (IFNt) for 24 hours at 37 ˚C and administered in the uterine cavity of patients 1 day prior to embryo transfer.

Trial Locations (1)

1330

RECRUITING

Nadezhda Women's Health Hospital, Sofia

All Listed Sponsors
lead

Nadezhda Women's Health Hospital

OTHER